Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
It represents a next-generation incretin-based compound of significant interest in metabolic disease research, with studied effects on energy homeostasis, insulin secretion, and lipid metabolism in preclinical models
Absolute contraindications Medullary thyroid cancer MEN-2 Pregnancy or breastfeeding Prior severe allergic reaction to GLP-1 medications Conditions requiring extra caution Gastroparesis or delayed gastric emptying History of pancreatitis Advanced diabetic retinopathy Use alongside medications that increase hypoglycemia risk These and a few other situations require individualized assessment, which is why specialty endocrine care matters
Although both drugs were extensively studied before approval, semaglutide has only been on the market since 2017 and tirzepatide since 2022
GIP signaling is commonly linked to broader incretin-based metabolic effects that influence nutrient handling and insulin response
Research & Education Tool Retatrutide Dosage Calculator Enter the vial amount, diluent volume, and target amount to estimate concentration, draw volume on a 1 mL U-100 syringe, and approximate vial yield
GLP-1s address multiple root causes of menopausal weight gain: 1
US$ 28.60
US$ 29.64
US$ 23.75
